Search for: "Takeda California" Results 41 - 60 of 74
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jul 2013, 9:33 am by Rajiv Kr. Choudhry
Refused P S Rao 1090/DEL/2007 ICAR  Refused, 3(k) P S Rao 4959/DELNP/2007 CALIFORNIA INSTITUTE OF TECHNOLOGY Refused P S Rao 1909/DELNP/2006 DUKE MANUFACTURING COMPANY Refused P S Rao 1594/DELNP/2006 TENNECO AUTOMOTIVE Refused P S Rao 2032/DELNP/2006 L'AIR LIQUIDE SOCIETE ANONYME Refused P S RAO 2301/MUM/2007 TATA MOTORS LIMITED Refused Pankaj Borkar 1023/KOLNP/2006 SIEMENS MEDICAL SOLUTIONS USA, INC. [read post]
2 Jun 2013, 8:40 pm by Patent Docs
Sandoz Inc. 3:13-cv-02418; filed May 29, 2013 in the Northern District of California • Plaintiffs: Takeda Pharmaceutical Co., Ltd.; Takeda Pharmaceuticals U.S.A., Inc.; Takeda Pharmaceuticals America, Inc. [read post]
1 Jun 2013, 1:42 pm
Recently the first Actos trial in the United States was held in California state court. [read post]
5 May 2013, 10:07 am
The California state court judge has tossed last week's Actos bladder cancer verdict and has reversed the $6.5 million damage award. [read post]
4 Mar 2013, 4:02 pm
Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court (Los Angeles) [read post]
23 Feb 2013, 11:37 am
Takeda Pharmaceuticals America, Inc., CGC-12-518535, California Superior Court (Los Angeles). [read post]
5 Sep 2012, 3:30 pm
Among the complaints is a California dangerous drug case involving 12 plaintiffs who believe that the reason they developed bladder cancer was because they were taking Actos. [read post]
6 Aug 2012, 1:24 pm by Brenda Fulmer
Thirteen individual have sued the makers of Nexium and Prevacid in California state court alleging the drug maker failed to adequately warn doctors and consumers that the acid reflux drugs cause bone loss and osteoporosis. [read post]
1 Aug 2012, 11:17 am
In an addition to multidistrict litigation cases, there are large consolidated court cases in California and Illinois. [read post]
17 Feb 2012, 2:00 am by Stephanie Figueroa
The post discusses dramatic results in two FCPA trials as well as while the Citigroup matter remains pending before the Second Circuit, a second settlement where the Court asked the SEC to address certain questions reached a conclusion. 5) California Corporate & Securities Law: Is A Director An “Official At The Highest Level Of Corporate Management”? [read post]
27 Jan 2012, 7:13 am by Ed Wallis
As a result, the FDA ordered the drug’s manufacturer, Takeda Pharmaceuticals North America, Inc., to update Actos symptoms on the drug’s label earlier this fall. [read post]
23 Jan 2012, 11:04 am
On January 4, 2012, a number of California Actos bladder cancer lawsuits were consolidated by the Los Angeles Superior Court. [read post]
12 Jan 2012, 6:44 am by Ed Wallis
Takeda Pharmaceuticals, the manufacturer of Actos, has indicated it intends to file a motion to transfer all of the California state court lawsuits over Actos to the federal MDL. [read post]
9 Jan 2012, 7:41 am by Ed Wallis
Plaintiff’s counsel countered this statement, arguing that the current California cases have a legitimate basis for filing in California jurisdiction due to the operations of their Takeda San Diego facility and will seek to oppose Takeda’s efforts to remove California Actos plaintiffs to Federal Court. [read post]
5 Jan 2012, 3:10 pm by Ed Wallis
Takeda and Eli Lilly & Company jointly promoted Actos in the United States since its launch in 1999; however as of 2006, Takeda solely assumed all marketing and sales responsibilities for Actos. [read post]
4 Jan 2012, 9:20 am by Ed Wallis
Takeda and Eli Lilly & Company jointly promoted Actos in the United States since its launch in 1999; however as of 2006, Takeda solely assumed all marketing and sales responsibilities for Actos. [read post]
11 Nov 2011, 7:31 am
Research Data Summary To address the long-term risk of bladder cancer associated with pioglitazone use, the drug manufacturer (Takeda) is conducting a ten-year, observational cohort study in patients with diabetes who are members of Kaiser Permanente Northern California (KPNC) health plan. [read post]
25 Aug 2011, 1:21 pm by Cal Warriner
It has now been disclosed that the risk of bladder cancer was raised in Europe when Takeda Pharmaceuticals sought regulatory approval to market Actos in Europe. [read post]